Voutsadakis from Sault Area Hospital and Northern Ontario School of Medicine discuss tumor mutation burden (TMB)—a novel ...

People with cancer may encounter checkpoint inhibitors as a treatment option but may not know where to start. This article ...

Researchers conducted a study to evaluate performance metrics of cognitive control across multiple tasks in both boys and girls with ADHD.

Research conducted by the Centenary Institute has revealed a promising new approach to tackling melanoma, an aggressive form ...

New InteractPrint tool analyzes how breast cancer epithelial cells impact cancer-immune interactions, enabling prediction of immune checkpoint inhibition response.

A local biotech has not only raised $95 million, but said it plans to bring its first drug into the clinic later this year in ...

Expanding Portfolio of Mast Cell Programs with Plans to Initiate a Phase 1b/2a study in Patients with Asthma in Q4 2024 Company to Host Key Opinion Leader Webinar on the Potential of Briquilimab in ...

The improvement in peak oxygen uptake “far exceeds” the threshold considered clinically meaningful, said Martin Maron.

Pheast scientists have demonstrated that blocking CD24 with PHST001 induces macrophage phagocytosis of multiple cancer subtypes in vitro, and have shown potent efficacy for PHST001 in vivo. In some ...

The analysis by US biotech Circular Genomics focuses on an assay that looks for a circular RNA (circRNA) blood biomarker that ...

MC2 Therapeutics Receives Positive Feedback from FDA pre-IND Meeting and Updates on Indication Expansion Strategy On track to file IND in ...

Cytokinetics has set out to prove that aficamten is a threat to Bristol Myers Squibb’s $13.1 billion heart disease drug ...